Target Details
| UniProt AC | Q07889 |
|---|---|
| Gene Symbol | SOS1 |
| Protein Name | Son of sevenless homolog 1 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00617 (RasGEF) PF00618 (RasGEF_N) PF00621 (RhoGEF) PF22697 (SOS1_NGEF_PH) |
Summary
- Multi-target molecules 766
- Clinical molecules 0
- Avg pChEMBL 8.12
KEGG Pathways (48)
- Acute myeloid leukemia
- Alcoholism
- B cell receptor signaling pathway
- Breast cancer
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- Choline metabolism in cancer
- Chronic myeloid leukemia
- Colorectal cancer
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endometrial cancer
- ErbB signaling pathway
- Estrogen signaling pathway
- Fc epsilon RI signaling pathway
- Focal adhesion
- FoxO signaling pathway
- Gap junction
- Gastric cancer
- Glioma
- GnRH signaling pathway
- Growth hormone synthesis, secretion and action
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Human cytomegalovirus infection
- Human papillomavirus infection
- Insulin signaling pathway
- JAK-STAT signaling pathway
- MAPK signaling pathway
- MicroRNAs in cancer
- Natural killer cell mediated cytotoxicity
- Neurotrophin signaling pathway
- Non-small cell lung cancer
- PI3K-Akt signaling pathway
- Pathways in cancer
- Phospholipase D signaling pathway
- Prolactin signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Relaxin signaling pathway
- Renal cell carcinoma
- T cell receptor signaling pathway
- Thermogenesis
- mTOR signaling pathway
Associated Diseases (3)
Active Molecules (766)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
QBFSGJGPCXIJGM
|
9.0 | IC50 | 2 | — | |
QCTLYLBEXZKCQQ
|
9.0 | IC50 | 2 | — | |
QDERCKRKDZNRIG
|
9.0 | IC50 | 2 | — | |
QDERCKRKDZNRIG
|
9.0 | IC50 | 2 | — | |
QLRPGLJAYUETBG
|
9.0 | IC50 | 2 | — | |
QVNKDWKSJOJSMI
|
9.0 | IC50 | 2 | — | |
QVNKDWKSJOJSMI
|
9.0 | IC50 | 2 | — | |
QVNKDWKSJOJSMI
|
9.0 | IC50 | 2 | — | |
QXMGEIYPWDDQCX
|
9.0 | IC50 | 2 | — | |
REVREZPDCDGFGC
|
9.0 | IC50 | 2 | — | |
RLCWCKHZJRMBFS
|
9.0 | IC50 | 2 | — | |
RLQDAGPMXXVPQM
|
9.0 | IC50 | 2 | — | |
RQPYOJQAMGQIAO
|
9.0 | IC50 | 2 | — | |
RUDSFSNPUJDDMF
|
9.0 | IC50 | 2 | — | |
RXELUWXNOJHEEJ
|
9.0 | IC50 | 2 | — | |
SGDPSOKNGBLBJZ
|
9.0 | IC50 | 2 | — | |
SSXKZHVOFRUTLS
|
9.0 | IC50 | 2 | — | |
TUIOCYJRMRRCKR
|
9.0 | IC50 | 2 | — | |
UCZREAVUXCUCOO
|
9.0 | IC50 | 2 | — | |
UUEXQVFACYHUFS
|
9.0 | IC50 | 2 | — | |
UUEXQVFACYHUFS
|
9.0 | IC50 | 2 | — | |
VBJCXRRBKBYGTG
|
9.0 | IC50 | 2 | — | |
VCOUWBMOTCQWNL
|
9.0 | IC50 | 2 | — | |
VGBCDEBUDZMQQH
|
9.0 | IC50 | 2 | — | |
VHCTXEMYIMMRJS
|
9.0 | IC50 | 2 | — | |
VHCTXEMYIMMRJS
|
9.0 | IC50 | 2 | — | |
VLGMPFODCAIUCX
|
9.0 | IC50 | 2 | — | |
VREMEYIGVQDHHO
|
9.0 | IC50 | 2 | — | |
WCKLUHXJBOHOGA
|
9.0 | IC50 | 2 | — | |
WHGPXTQJFBAXFS
|
9.0 | IC50 | 2 | — | |
WJXAGUJJMJMQSI
|
9.0 | IC50 | 2 | — | |
WLZBZNGHYJAJSO
|
9.0 | IC50 | 2 | — | |
XCDDXKCNGCKIJU
|
9.0 | IC50 | 2 | — | |
XCVQZXMDZXSNPZ
|
9.0 | IC50 | 2 | — | |
XHMDVJPQZNBCDU
|
9.0 | IC50 | 2 | — | |
XHVNNIKEKFZCQN
|
9.0 | IC50 | 2 | — | |
XHVNNIKEKFZCQN
|
9.0 | IC50 | 2 | — | |
XMKJQVBDKMRJNL
|
9.0 | IC50 | 2 | — | |
XNJHRLGOJPVESX
|
9.0 | IC50 | 2 | — | |
XXJVFJGZBDFFGR
|
9.0 | IC50 | 2 | — | |
YMSULEFZKBQFGY
|
9.0 | IC50 | 2 | — | |
YZBAKMDIMBNVGZ
|
9.0 | IC50 | 2 | — | |
ZECWYGKICHRGFU
|
9.0 | IC50 | 2 | — | |
ZFGFTOBEPQTGJO
|
9.0 | IC50 | 2 | — | |
ZHZYGNMJAXEYEV
|
9.0 | IC50 | 2 | — | |
ZULMCEOIMAGIKA
|
9.0 | IC50 | 2 | — | |
ZUXXZIUWFGUYLM
|
9.0 | IC50 | 2 | — | |
CVSHNLRGHUWWNN
|
8.8 | IC50 | 2 | — | |
DYBWJYGHLSCLSK
|
8.8 | IC50 | 2 | — | |
FQKMRHYIFJIBMT
|
8.8 | IC50 | 2 | — |